Precision medicine is a personalized diagnosis and treatment based on big data with a wide range of applications
Precision medicine is not exactly the same in different countries, for example, the American version of precision medicine puts more emphasis on collecting and analyzing comprehensive data information about the population, while the British version focuses on the collection of clinical data, and the Chinese version places more emphasis on maximizing benefits. For example, the U.S. version emphasizes the collection and analysis of comprehensive data information about the population, while the U.K. version focuses on the collection of clinical data, and the Chinese version emphasizes the maximization of benefits. Although there are different interpretations of precision medicine in the international arena, the definitions of precision medicine in each country include diagnosis and treatment based on big data, with a broader scope of application, and emphasis on personalization and differentiation.
Policy guidance and support for the development of the precision medicine industry
From the perspective of the global political and legal environments of the precision medicine industry, many countries around the world have launched precision medicine-related development programs to encourage and support the development of the precision medicine industry, and the representative programs are the United Kingdom (100,000 genomes), the United States ("All of Us"), and the United States ("All of Us"). Representative programs include the United Kingdom (100,000 Genomes Project), the United States ("All of Us" research program), Australia (Genomics Healthy Futures Mission) and so on.
Gene sequencing technology, cell and gene therapy technology continues to develop
From the 1970s Sanger invented the double deoxyribonucleotide end termination method and Gilbert and Maxam invented chemical degradation method as the symbol of the first generation of sequencing technology, so far, the development of gene sequencing technology a** ** Emergence of 4 generations of sequencing technology. Currently, second-generation sequencing technology is the mainstream of the market, which is typically represented by Illumina's Solexa technology, Roche's 454 technology and Life
tech's SOLID technology. In recent years, Heloscope's single-molecule sequencing technology and PacBio's SMRT technology, representing the third generation of technology, as well as the fourth generation of nanopore sequencing technology, have emerged, marking the future development direction of sequencing technology.
The R&D and production of cell and gene therapy (CGT) mainly includes three processes: plasmid production, virus production, and preparation of T cells. International technologies related to cell and gene therapy can be categorized into cell therapy technology and gene therapy technology, as shown in the following table. At present, cell and gene therapy shows a trend of development from traditional cell therapy to combination with gene therapy.
Global Precision Medicine Industry Development Environment Summary
From the perspective of policy environment, many countries around the world have launched precision medicine-related development programs to encourage, support and guide the development of the precision medicine industry; from the perspective of technological environment, the fourth-generation sequencing technology and gene therapy technology have emerged one after another to lay the foundation for the industry development. Overall, policy and technology drive the development of the industry.
For more research and analysis of this industry, please refer to Prospect Industry Research Institute's "Global Precision Medicine Industry Development Prospect Forecast and Investment Strategy Planning Analysis Report".